BarcelonaUriach is not enough. The Catalan pharmaceutical company, which has accumulated significant growth in recent years, is completing a major corporate operation in Germany with the purchase of a company dedicated to self-care products. As confirmed by industry sources in ARA, negotiations between the two parties are virtually closed and the agreement is complete in the absence of only the signature. In this way, the Uriach family business would grow in central Europe, where the products of consumer health, which do not require a prescription, are widely accepted, to the point that Germany is the continent’s leading market. Uriach, who is making his 2020 results public today, has not confirmed this information.